Scott J. Knoer, MS, PharmD, FASHP, EVP and CEO of APhA, discussed the value of the pharmacist on patient care teams and how this value could be supported and enhanced in the future.
Although the CDC and FDA have lifted the pause on Johnson & Johnson’s COVID-19 vaccine, Humphreys said the vaccine now comes with a warning label, and ongoing safety reviews will be paramount to ensure its continued safety.
Health care practitioners and manufacturers must change practice patterns and management strategies.
Kenneth Komorny, PharmD, BCPS, a co-lead on development of National Comprehensive Cancer Network recommendations for biosimilar management, explains some of the positions the NCCN has taken.
Study finds that cannabidiol (CBD) and expectancies for receiving CBD do not appear to reduce experimental pain intensity but do make the pain feel less unpleasant.